Reference number : GC-2017-Q1-02749, amendment number : , agreement type : G, recipient legal name : Shaw, Gary (The University of Western Ontario), recipient country : CA, recipient province : nan, recipient city : Ontario, recipient postal code : nan, program name english : Discovery Grants Program - Individual, program name french : Programme de subventions à la découverte - individuelles, program purpose english : The ubiquitin-dependent proteolysis pathway is one of the most important regulatory mechanisms in the cell. It is responsible for the turnover of damaged or misfolded proteins that are the hallmark of neurodegenerative diseases such as Alzheimer&rsquo;s, Parkinson&rsquo;s and Amyotrophic Lateral Sclerosis diseases. The process of ubiquitination involves the transfer of ubiquitin (Ub) between a series of proteins (E1, E2, E3) until it labels a lysine of a protein targeted for degradation. In the second step of this cascade the Ub molecule is transferred to the catalytic cysteine of one of ~60 possible E2 enzymes forming a covalent but highly unstable E2~Ub thiolester intermediate. The E2~Ub conjugate is responsible for recruiting either a RING or HECT E3 enzyme in order to transfer the Ub to a substrate. Recently proteomic experiments have identified that Ub can be post-translationally phosphorylated and acetylated. Specifically, Ub is phosphorylated at positions T7, T12, T14, S20, S57, Y59 and S65 and acetylated at positions K6, K11, K27, K33, K48 and K63. Our goal is to mechanistically understand the consequences of phosphorylation and acetylation on the structure, stability and folding of Ub and the impact of these modifications on the transfer of Ub to/from the central E2 conjugating enzyme. 
 
The following questions will be addressed; 
 
(1) How does phosphorylation and acetylation alter the conformation and stability of Ub, 
(2) How do phosphorylation and acetylation impact the transfer of Ub to/from an E2 enzyme, 
(3) How are the conformations and structures of different E2~Ub conjugates modified by phosphorylation and acetylation. 
 
The aims and objectives to answer these questions are, 
 
(1) Synthesize and express selected phosphorylated and acetylated Ub proteins using orthogonal translation methods, 
(2) Use chemical and thermal denaturation methods to determine the stabilities and folding of post-translationally modified Ub proteins, 
(3) Use NMR spectroscopy to examine the conformations of Ub, phosphorylated at S7, S20 and S57, or acetylated at K6, K11, K48 and K63. Determine structures of modified Ub that indicate the largest apparent changes to uncover the atomic level impact of the post-translational modification, 
(4) Use kinetic experiments to determine the rates of loading and unloading of post-translationally modified Ubs with selected E2 enzymes, 
(5) Assemble stable E2~Ub conjugate proteins with phosphorylated or acetylated Ub proteins and different E2 enzymes. Determine how post-translationally modified Ub alters the conformations of E2~Ub conjugates. 
 
The results of this work will identify how post-translational modifications of Ub alter the processing of this protein by the E2 conjugating enzyme and ultimately how these modifications affect the entire ubiquitination pathway., program purpose french : The ubiquitin-dependent proteolysis pathway is one of the most important regulatory mechanisms in the cell. It is responsible for the turnover of damaged or misfolded proteins that are the hallmark of neurodegenerative diseases such as Alzheimer&rsquo;s, Parkinson&rsquo;s and Amyotrophic Lateral Sclerosis diseases. The process of ubiquitination involves the transfer of ubiquitin (Ub) between a series of proteins (E1, E2, E3) until it labels a lysine of a protein targeted for degradation. In the second step of this cascade the Ub molecule is transferred to the catalytic cysteine of one of ~60 possible E2 enzymes forming a covalent but highly unstable E2~Ub thiolester intermediate. The E2~Ub conjugate is responsible for recruiting either a RING or HECT E3 enzyme in order to transfer the Ub to a substrate. Recently proteomic experiments have identified that Ub can be post-translationally phosphorylated and acetylated. Specifically, Ub is phosphorylated at positions T7, T12, T14, S20, S57, Y59 and S65 and acetylated at positions K6, K11, K27, K33, K48 and K63. Our goal is to mechanistically understand the consequences of phosphorylation and acetylation on the structure, stability and folding of Ub and the impact of these modifications on the transfer of Ub to/from the central E2 conjugating enzyme. 
 
The following questions will be addressed; 
 
(1) How does phosphorylation and acetylation alter the conformation and stability of Ub, 
(2) How do phosphorylation and acetylation impact the transfer of Ub to/from an E2 enzyme, 
(3) How are the conformations and structures of different E2~Ub conjugates modified by phosphorylation and acetylation. 
 
The aims and objectives to answer these questions are, 
 
(1) Synthesize and express selected phosphorylated and acetylated Ub proteins using orthogonal translation methods, 
(2) Use chemical and thermal denaturation methods to determine the stabilities and folding of post-translationally modified Ub proteins, 
(3) Use NMR spectroscopy to examine the conformations of Ub, phosphorylated at S7, S20 and S57, or acetylated at K6, K11, K48 and K63. Determine structures of modified Ub that indicate the largest apparent changes to uncover the atomic level impact of the post-translational modification, 
(4) Use kinetic experiments to determine the rates of loading and unloading of post-translationally modified Ubs with selected E2 enzymes, 
(5) Assemble stable E2~Ub conjugate proteins with phosphorylated or acetylated Ub proteins and different E2 enzymes. Determine how post-translationally modified Ub alters the conformations of E2~Ub conjugates. 
 
The results of this work will identify how post-translational modifications of Ub alter the processing of this protein by the E2 conjugating enzyme and ultimately how these modifications affect the entire ubiquitination pathway., agreement title english : Mechanisms of E2 Conjugating Enzymes, agreement title french : Mechanisms of E2 Conjugating Enzymes, agreement number : RGPIN, agreement value : 250000.0, agreement start date : 2017-05-10, agreement end date : nan, description english : nan, description french : nan, expected results english : nan, expected results french : nan, additional information english : Grant or Award spanning more than one fiscal year. (2017-2018 to 2022-2023), additional information french : Subvention ou bourse octroyée s'appliquant à plus d'un exercice financier. (2017-2018 à 2022-2023), owner organization : nserc-crsng, owner organization title : Natural Sciences and Engineering Research Council of Canada | Conseil de recherches en sciences naturelles et en génie du Canada